Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.

[Long-Term Survival of a Patient with Stage IV Breast Cancer and An Intrathoracic Space-Occupying Metastatic Lesion]

Long-term Remission under Disitamab Vedotin (RC48) in HR-positive/HER2-positive Metastatic Breast Cancer with Brain Meningeal, and Bone Marrow Involvement: A Case Report.

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Multiple metastases of human epidermal growth factor receptor 2‐positive, hormone receptor‐positive, pT1a pN0 breast cancer within 1 year after surgery: A case report

Case Report: Prolonged Clinical Benefit of ESG401, a Novel Trophoblast Cell-Surface Antigen 2 (Trop-2) Antibody-Drug Conjugate (ADC), in a Patient with Endocrine- Refractory Hormone Receptor-Positive, HER-2 Negative Metastatic Breast Cancer

Asking health and social care staff to go the extra QA mile.

Surgical Resection of Advanced Gastric Cancer Following Trastuzumab/Oxaliplatin/Capecitabine Combination Therapy

Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts

Long-term Disease-Free Survival Achieved by Anti-Angiogenic Therapy Plus Surgery in a Hepatocellular Carcinoma Patient with Extensive Liver Involvement and Lung Metastases.

[A Case of Breast Metaplastic Carcinoma and Distant Metastasis with Complete Response to Immunotherapy]

[A Case of Long-Term Survival after Surgeries for Gastric Cancer and Metachronous Ovarian Metastasis]

Aroma biogenesis and distribution between olive pulps and seeds with identification of aroma trends among cultivars.

Utilization of soy protein isolate mixed with rice protein in Japanese women.

Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report

[Complete Response of Liver Metastases from a HER2-Positive Gastric Cancer Treated with Combined S-1/Trastuzumab Chemotherapy]

Clinical Features of Long-Term Survivors (LTS) of Advanced Hepatocellular Carcinoma Undergoing Molecular Targeted Therapy (MTT).

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report

[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]

[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment]

Proanthocyanidins in wild sea buckthorn (Hippophaë rhamnoides) berries analyzed by reversed-phase, normal-phase, and hydrophilic interaction liquid chromatography with UV and MS detection.